Incyte Corp
NASDAQ:INCY
Incyte Corp
NASDAQ:INCY
Price:
57.79 USD
0.86%
Market Closed
Updated:
Jun 1, 2024
Incyte Corp
Other Equity
|
Incyte Corp
Other Equity Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Incyte Corp
NASDAQ:INCY
|
Other Equity
-$6.2m
|
CAGR 3-Years
33%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Equity
-$2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-19%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Equity
$69m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Equity
-$190m
|
CAGR 3-Years
39%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-4%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Equity
$27.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Equity
-$77.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Incyte Corp's Other Equity?
Other Equity
-6.2m
USD
-6.2m
USD
Based on the financial report for Mar 31, 2024, Incyte Corp's Other Equity amounts to -6.2m USD.
What is Incyte Corp's Other Equity growth rate?
Other Equity CAGR 5Y
8%
8%
The average annual Other Equity growth rates for Incyte Corp have been 33% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
